Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
WEAV
HoldPremium GrowerWeave Communications, Inc. · Healthcare · United States · $583M · Avg Vol: $31M/d
COMPANY DESCRIPTION
Weave Communications, Inc. provides an all-in-one customer communication and engagement software platform tailored for small-to-medium-sized healthcare practices, such as dental and optometry clinics. The company's platform integrates directly with proprietary practice management systems, creating a high-switching-cost moat. It operates as a leading niche SaaS provider, streamlining patient scheduling, billing, and communication workflows.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 142.1M | 170.5M | 204.3M | 239.0M | 18.9% | 257.8M | 274.2M | 310.9M | 14.0% |
| EPS | -0.76 | -0.46 | -0.40 | -0.37 | — | -0.27 | — | — | — |
| Shares | 65.7M | 70.1M | 73.2M | 78.4M | +19.2% | 80.0M | — | — | — |
| Debt | 73.6M | 59.5M | 56.1M | 52.2M | -10.8% | 51.4M | — | — | — |
| Equity | 83.2M | 79.0M | 67.0M | 82.4M | -0.3% | — | — | — | — |
| Op CF | -12.8M | 10.2M | 14.1M | 17.5M | 31.0% | 16.9M | — | — | — |
| Inv CF | -54.0M | -7.7M | 8.9M | -6.8M | — | — | — | — | — |
| Fin CF | -7.2M | -13.7M | -22.2M | -7.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of WEAV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| WEAV | Weave Communications, Inc.(you) | $583M | 64 | Hold |
| CTEV | Claritev Corporation | $668M | 66 | Buy |
| NRC | NRC Health | $483M | 73 | Buy |
| MDRX | Veradigm Inc. | $517M | 51 | Hold |
| OMDA | Omada Health, Inc. | $1.5B | 65 | Buy |
| PHR | Phreesia, Inc. | $751M | 48 | Hold |
| OMCL | Omnicell, Inc. | $1.5B | 66 | Buy |
| EVH | Evolent Health, Inc. | $520M | 43 | Hold |
| GDRX | GoodRx Holdings, Inc. | $1.2B | 77 | Buy |
| CARL | Carlsmed, Inc. | $461M | 40 | Hold |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.1%